CW2IP2: Imaging and Diagnostic Assessments
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- University of Pennsylvania
- Study ID
- NCT06083467
- Status
- Recruiting
Conditions
- Tauopathies
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - 85 Years
- Healthy Volunteers
- Accepted
Interventions
- Brain MRI Scan — DIAGNOSTIC_TESTMRI scan of the brain
- Neurologic exam — BEHAVIORALNeurologic exam and assessments, including video interview
Study Details
This current protocol will provide the key data to help determine the specificity of our to-be-developed radiotracers by implementing a multi-site diagnostic assessment core and PET imaging of A-beta amyloid (may be completed at some sites as part of another protocol) that is commonly deposited in the brains of people with Parkinson's Disease (PD), Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP) or Frontotemporal Dementia (FTD) as well as healthy controls. This multicenter U19 grant is centered at U Pennsylvania (U Penn) (PI: Robert Mach) in collaboration with U Pittsburgh (Pitt), Yale University, U of California at San Francisco (UCSF) and Washington University in St. Louis (WU). U Penn will act as the single IRB of Record (sIRB) for this multi-center project and subjects will be recruited from all sites.
Key Dates
- Start date
- Jul 20, 2023
- Status verified
- Nov 2025
- Primary completion
- Jul 31, 2028
- Completion
- Jul 31, 2028
Study Design
- Enrollment
- 94 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Other: Diagnostic AssessmentsSubjects may receive a brain MRI and neurological exam with diagnostic assessments.
Primary Outcome Measure
Disease diagnosis [ Time Frame: 8 weeks ]
Central Contacts
- Erin o Schubert2155736569
- Refatun Momo215-573-6693
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Ilya Nasrallah, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Philadelphia, PA
Related Studies
- Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15EARLY_PHASE1 · Recruiting · University of Pennsylvania · Philadelphia, Pennsylvania
- Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503EARLY_PHASE1 · Recruiting · University of Pennsylvania · New Haven, Connecticut
- Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183AEARLY_PHASE1 · Recruiting · University of Pennsylvania · San Francisco, California